Element Biosciences logo

Element Biosciences

Challenger

Element Biosciences makes the AVITI benchtop DNA sequencer; raised $277M Series D in 2024 (led by Wellington Management, Samsung) for $680M+ cumulative; install base grew from ~40 to 190+ units in 12 months.

Best for: Next-Generation DNA Sequencing
52
AI Score
Grade C
AI Visibility Score (Beta)
Life Sciences & BioTechNext-Generation DNA SequencingWebsiteUpdated October 2026

Company Overview

About Element Biosciences

Element Biosciences is a genomics company developing next-generation DNA sequencing instruments and reagents designed to democratize access to high-quality, cost-effective sequencing. Founded in 2017 by veterans from Illumina, Life Technologies, and other genomics leaders, the company is headquartered in San Diego, California. Its flagship product, the AVITI System, is a benchtop sequencer that combines high accuracy, flexible throughput, and competitive per-sample costs — making research-grade sequencing accessible to academic labs, biotech companies, agricultural research programs, and clinical settings that previously could not justify large capital outlays for sequencing infrastructure.

Business Model & Competitive Advantage

Element Biosciences raised over $277M in a Series D round in July 2024 led by Wellington Management with participation from Samsung Electronics, Fidelity, Foresite Capital, T. Rowe Price, and Venrock, bringing cumulative funding to over $680M. The AVITI install base grew from approximately 40 units to more than 190 in the 12 months preceding the Series D close — representing substantial commercial momentum in a market dominated by Illumina. The follow-on AVITI24 platform, which combines state-of-the-art sequencing with cyto-profiling in a single integrated instrument, represents the company's expansion into multi-omics and spatial biology workflows.

Competitive Landscape 2025–2026

Element competes directly with Illumina, the long-dominant player in short-read sequencing, as well as with Oxford Nanopore (long-read) and Pacific Biosciences (HiFi). Element differentiates through its proprietary AVITI chemistry — which the company claims delivers fewer errors and lower costs than comparable Illumina platforms — alongside open reagent compatibility that reduces vendor lock-in. The company supports customers across academia, biotech, oncology, agricultural science, and pandemic preparedness in more than 25 countries, with cloud-based data analysis tools completing the end-to-end workflow.

Founded
2017
Headquarters
San Diego, California
Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Element Biosciences is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

52
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Schrödinger logo

Schrödinger

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechAi PoweredSaasPlatformAnalytics

Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo

Illumina logo

Illumina

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechAnalyticsHardwarePlatformFortune500

Illumina was founded in 1998 in San Diego and has grown into the undisputed leader in next-generation sequencing (NGS), with approximately 80% global market share across research and clinical applicat

10x Genomics logo

10x Genomics

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechHardwareAnalyticsPlatform

10x Genomics was founded in 2012 in Pleasanton, California by Serge Saxonov, Ben Hindson, and Kevin Ness. The company developed the Chromium platform for single-cell RNA sequencing (scRNA-seq), enabli

For Element Biosciences

Claim This Profile

Are you from Element Biosciences? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Element Biosciences Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Element Biosciences vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →